Neurocognitive disorders encompass a broad range of conditions characterized by impairments in cognitive function, memory, and behavior, posing substantial ...

A new study suggests that the communication patterns within the brains of individuals with Alzheimer’s disease are less ...

For individuals who are currently cognitively unimpaired, the risk of MCI and dementia increases with increasing amyloid PET centiloid value.

Neurogen Biomarking and Tasso, Inc. today announced a broad partnership agreement in which Neurogen will adopt Tasso's ...

The NTU team plans to keep following the study participants to see if those with clogged brain drains do indeed go on to ...

A neuroimaging study of individuals spanning the Alzheimer’s disease spectrum found that the attenuated anticorrelation ...

Distinguishing early forms of cognitive impairment from normal aging can be a difficult diagnostic puzzle. Most primary care ...

When Dan and Andrea Harrington attended their daughter’s graduation from medical school, it was a life-changing event. It’s ...

In the same way imaging and biomarker analytics revolutionized cancer and cardiology, AI-driven cognitive analytics will redefine brain health, says one CEO. Next year may be when private insurers ...

Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by cognitive decline such as memory loss ...

A new meta-analysis of six randomized controlled trials shows that lithium supplementation does not significantly slow cognitive decline in people with mild cognitive impairment or Alzheimer’s disease ...

New research published in the journal Nature suggests that modest doses of lithium orotate may prevent or even reverse ...